EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Kera Capital Partners Inc. Acquires Shares of 8,391 AbbVie Inc. $ABBV - Markets Daily
Stephens Inc. AR Boosts Position in AbbVie Inc. $ABBV
Robeco Schweiz AG Cuts Holdings in AbbVie Inc. $ABBV - Markets Daily
Robeco Schweiz AG Decreases Stock Position in AbbVie Inc. $ABBV
Kera Capital Partners Inc. Makes New Investment in AbbVie Inc. $ABBV - Stock Observer
WealthPlan Investment Management LLC Has $17.12 Million Stake in AbbVie Inc. $ABBV - Daily Political
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study
Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation
AbbVie Secures Tariff Relief Pact
Polaris Capital Management LLC Cuts Position in AbbVie Inc. $ABBV
PKO Investment Management Joint Stock Co Sells 3,500 Shares of AbbVie Inc. $ABBV
AbbVie reaches 3-year deal with White House to lower drug prices
And then there was one: Abbvie reaches MFN pricing deal | BioWorld
RemeGen shares trade over 9% amid AbbVie licensing deal - Chinadaily.com.cn
Dow Jones Top Company Headlines at 9 PM ET: AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices | Target's ... | Morningstar
AbbVie Pledges $100 Billion US Investment to Avoid Tariffs
Is AbbVie (ABBV) Pricing Look Attractive After Strong Multi Year Share Gains
Trump administration strikes deal with AbbVie to cut costs of certain drugs | CNN Politics
AbbVie announces voluntary agreement with the Trump administration | Markets Insider
Meeder Asset Management Inc. Trims Stock Position in AbbVie Inc. $ABBV - Markets Daily
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $14.71 Million Stock Holdings in AbbVie Inc. $ABBV
AbbVie to License RemeGen Cancer Drug | Morningstar
Meeder Asset Management Inc. Trims Stake in AbbVie Inc. $ABBV
Tema Etfs LLC Grows Stock Holdings in AbbVie Inc. $ABBV
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
Citizens Financial Group Inc. RI Grows Stake in AbbVie Inc. $ABBV
Tema Etfs LLC Raises Holdings in AbbVie Inc. $ABBV - Stock Observer
West To Sell SmartDose 3.5mL On-Body Delivery System To AbbVie For $112.5 Mln
AbbVie Inc. $ABBV Shares Acquired by Sumitomo Mitsui Trust Group Inc. - Daily Political
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat
REGENXBIO Highlights Key 2026 Catalysts and Announces Positi
AbbVie Inc. $ABBV Shares Sold by New York State Teachers Retirement System
AbbVie Inc. $ABBV Shares Bought by Legacy Trust - Markets Daily
AbbVie Inc. $ABBV Stake Raised by Associated Banc Corp
AbbVie Inc. $ABBV Shares Acquired by Legacy Trust - Stock Observer
Oliver Luxxe Assets LLC Acquires 2,517 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research
AbbVie Inc. $ABBV Shares Bought by Rede Wealth LLC
Revolution Medicines (NASDAQ:RVMD) CFO Jack Anders Sells 10,000 Shares - Stock Observer
AbbVie (NYSE:ABBV) Shares Down 1.8% - Here's Why
STAT's Adam Feuerstein says Revolution Medicines canceled meeting | Markets Insider
What Catalysts Could Shift AbbVie's Story As Analysts Rework Targets And Drug Expectations
Oregon Public Employees Retirement Fund Has $46.75 Million Position in AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Holdings Decreased by State of Alaska Department of Revenue
Nisa Investment Advisors LLC Boosts Holdings in AbbVie Inc. $ABBV - Markets Daily
Revolution Medicines (NASDAQ:RVMD) Reaches New 12-Month High - Still a Buy? - Markets Daily
AbbVie Inc. $ABBV Shares Bought by Duncker Streett & Co. Inc.
AbbVie Inc. $ABBV Stake Raised by Oregon Public Employees Retirement Fund - Stock Observer
AbbVie Inc. $ABBV Shares Acquired by Capital Investment Advisors LLC
Is AbbVie (ABBV) Still Attractive After Strong 1-Year And 5-Year Share Price Gains?
AbbVie (NYSE:ABBV) Updates FY 2025 Earnings Guidance - Stock Observer
ABBV: Future Returns Will Depend On Post-Humira Immunology And Pipeline Execution
An updated definition of freezing of gait
Health Care Down Amid Deal Skepticism - Health Care Roundup | Morningstar
AbbVie (NYSE:ABBV) Trading Down 3.9% - Here's Why
Traders Purchase High Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - Markets Daily
AbbVie Flags $1.3B Charge, Cuts Fourth-Quarter EPS Outlook
Legacy CG LLC Buys 14,257 Shares of AbbVie Inc. $ABBV
AbbVie (ABBV) Stock Falls After Company Denies Revolution Medicines Buyout Talks
Investors Purchase Large Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - Stock Observer
AbbVie Inc. $ABBV Stock Position Increased by HB Wealth Management LLC
AbbVie (NYSE:ABBV) Issues FY 2025 Earnings Guidance
AbbVie (NYSE:ABBV) Releases Q4 2025 Earnings Guidance
AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.73
AbbVie Inc. $ABBV Stock Holdings Increased by CX Institutional
AbbVie Denies Acquisition Talks with Revolution Medicines Amid Stock Volatility, ETPharma
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
AbbVie (NYSE:ABBV) Shares Up 4.3% - What's Next?
AbbVie Says It's Not in Talks to Buy Revolution Medicines (1)
AbbVie denies media reports of talks to buy Revolution Medicines
Dow Jones Top Company Headlines at 3 PM ET: AbbVie Near Deal for Revolution Medicines | Anthropic ... | Morningstar
AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73
Securian Asset Management Inc. Sells 7,037 Shares of AbbVie Inc. $ABBV - Markets Daily
KLP Kapitalforvaltning AS Has $172.38 Million Stake in AbbVie Inc. $ABBV - Markets Daily
AbbVie Inc. $ABBV Stake Boosted by Park Avenue Securities LLC
AbbVie Inc. $ABBV Shares Purchased by KLP Kapitalforvaltning AS
Sivik Global Healthcare LLC Takes Position in AbbVie Inc. $ABBV
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
Assessing AbbVie (ABBV) Valuation After Recent Share Price Gain And Mixed Return Profile
AbbVie Inc. $ABBV Shares Acquired by Cerity Partners LLC
AbbVie Inc. $ABBV Stock Holdings Increased by Capital & Planning LLC
AbbVie Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis
AbbVie (NYSE:ABBV) Stock Price Up 1.7% - Still a Buy?
AbbVie Inc. $ABBV Shares Bought by Spirepoint Private Client LLC
Greenleaf Trust Sells 28,666 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Lifted by Torray Investment Partners LLC
MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus
AbbVie Inc. $ABBV Shares Purchased by Sitrin Capital Management LLC
Will AbbVie's (ABBV) Zelgen Lung Cancer Deal Reshape Its Post‑Humira Resilience Narrative?
Torray Investment Partners LLC Has $23.53 Million Stake in AbbVie Inc. $ABBV - Stock Observer
Geneos Wealth Management Inc. Cuts Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Stock Price Down 3.8% - Time to Sell?
Promising Pharmaceutical Stocks To Follow Now - January 5th - Markets Daily
